Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy PerkinElmer stock in Canada | $176.38
Own PerkinElmer shares in just a few minutes.
PerkinElmer Inc is a diagnostics & research business based in the US. PerkinElmer shares (PKI) are listed on the NYSE and all prices are listed in US Dollars. PerkinElmer employs 14,000 staff and has a trailing 12-month revenue of around USD$4.9 billion.
How to buy shares in PerkinElmer
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PKI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy PerkinElmer stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in PerkinElmer?
- Has coronavirus impacted PerkinElmer shares?
- PerkinElmer shares summary
- Compare share dealing platforms
- Is PerkinElmer stock a buy or sell?
- PerkinElmer performance over time
- Can I short PerkinElmer shares?
- Is PerkinElmer suitable for ethical investing?
- Are PerkinElmer shares over-valued?
- PerkinElmer's financials
- How volatile are PerkinElmer shares?
- Does PerkinElmer pay a dividend?
- Have PerkinElmer shares ever split?
- Other common questions
How has Coronavirus impacted PerkinElmer's stock price?
Since the stock market crash in March caused by coronavirus, PerkinElmer's stock price has had significant positive movement.
Its last market close was $176.38, which is 47.36% up on its pre-crash value of $92.85 and 180.37% up on the lowest point reached during the March crash when the stocks fell as low as $62.91.
If you had bought $1,000 worth of PerkinElmer stocks at the start of February 2020, those stocks would have been worth $730.74 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,899.61.
PerkinElmer stock priceUse our graph to track the performance of PKI stocks over time.
PerkinElmer shares at a glance
|Latest market close||$176.38|
|52-week range||$119.79 - $191.92|
|50-day moving average||$178.07|
|200-day moving average||$160.36|
|Wall St. target price||$179.17|
|Dividend yield||$0.28 (0.16%)|
|Earnings per share (TTM)||$10.52|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
PerkinElmer price performance over time
|1 week (2021-10-18)||3.52%|
|1 month (2021-09-24)||-3.55%|
|3 months (2021-07-25)||15.15%|
|6 months (2021-04-23)||30.68%|
|1 year (2020-10-23)||41.73%|
|2 years (2019-10-25)||104.55%|
|3 years (2018-10-25)||109.40%|
|5 years (2016-10-25)||244.76%|
Is PerkinElmer under- or over-valued?
Valuing PerkinElmer stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PerkinElmer's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PerkinElmer's P/E ratio
PerkinElmer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, PerkinElmer shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
PerkinElmer's PEG ratio
PerkinElmer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 36.3685. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PerkinElmer's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
PerkinElmer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.9 billion.
The EBITDA is a measure of a PerkinElmer's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.9 billion|
|Operating margin TTM||32.93%|
|Gross profit TTM||$2.1 billion|
|Return on assets TTM||13%|
|Return on equity TTM||32.81%|
|Market capitalisation||$22.3 billion|
TTM: trailing 12 months
Shorting PerkinElmer shares
There are currently 2.7 million PerkinElmer shares held short by investors – that's known as PerkinElmer's "short interest". This figure is 21.9% down from 3.5 million last month.
There are a few different ways that this level of interest in shorting PerkinElmer shares can be evaluated.
PerkinElmer's "short interest ratio" (SIR)
PerkinElmer's "short interest ratio" (SIR) is the quantity of PerkinElmer shares currently shorted divided by the average quantity of PerkinElmer shares traded daily (recently around 713230.54830287). PerkinElmer's SIR currently stands at 3.83. In other words for every 100,000 PerkinElmer shares traded daily on the market, roughly 3830 shares are currently held short.
However PerkinElmer's short interest can also be evaluated against the total number of PerkinElmer shares, or, against the total number of tradable PerkinElmer shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PerkinElmer's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 PerkinElmer shares in existence, roughly 20 shares are currently held short) or 0.0269% of the tradable shares (for every 100,000 tradable PerkinElmer shares, roughly 27 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PerkinElmer.
PerkinElmer's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like PerkinElmer.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
PerkinElmer's total ESG risk score
Total ESG risk: 21.66
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and PerkinElmer's overall score of 21.66 (as at 01/01/2019) is pretty good – landing it in it in the 25th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like PerkinElmer is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
PerkinElmer's environmental score
Environmental score: 3.15/100
PerkinElmer's environmental score of 3.15 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that PerkinElmer is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
PerkinElmer's social score
Social score: 12.09/100
PerkinElmer's social score of 12.09 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that PerkinElmer is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
PerkinElmer's governance score
Governance score: 9.42/100
PerkinElmer's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that PerkinElmer is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
PerkinElmer's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. PerkinElmer scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that PerkinElmer has, for the most part, managed to keep its nose clean.
PerkinElmer share dividends
Dividend payout ratio: 2.22% of net profits
Recently PerkinElmer has paid out, on average, around 2.22% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.16% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), PerkinElmer shareholders could enjoy a 0.16% return on their shares, in the form of dividend payments. In PerkinElmer's case, that would currently equate to about $0.28 per share.
While PerkinElmer's payout ratio might seem low, this can signify that PerkinElmer is investing more in its future growth.
PerkinElmer's most recent dividend payout was on 12 November 2021. The latest dividend was paid out to all shareholders who bought their shares by 21 October 2021 (the "ex-dividend date").
Have PerkinElmer's shares ever split?
PerkinElmer's shares were split on a 2:1 basis on 4 June 2001. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your PerkinElmer shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for PerkinElmer shares which in turn could have impacted PerkinElmer's share price.
PerkinElmer share price volatility
Over the last 12 months, PerkinElmer's shares have ranged in value from as little as $119.788 up to $191.9239. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while PerkinElmer's is 1.1143. This would suggest that PerkinElmer's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.
Stocks similar to PerkinElmer
Frequently asked questions
PerkinElmer in the news
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
PerkinElmer (PKI) Sees Hammer Chart Pattern: Time to Buy?
What Is The Ownership Structure Like For PerkinElmer, Inc. (NYSE:PKI)?
More on investing
Stock trading doesn’t have to be expensive. Using Finder’s proprietary algorithm, we’ve identified the best cheap Canadian and US stocks to buy now.Read more…
Steps to owning and managing Cue Health stocks, with 24-hour and historical pricing before you buy.Read more…
Steps to owning and managing ARBK stock, with 24-hour and historical pricing before you buy.Read more…
More guides on Finder
How to buy AirSculpt Technologies (AIRS) stock in Canada when it goes public
Everything we know about the AirSculpt Technologies IPO, plus information on how to buy in.
How to buy Candela Medical (CDLA) stock in Canada when it goes public
Everything we know about the Candela Medical IPO, plus information on how to buy in.
How to buy Ensemble Health Partners (ENSB) stock in Canada when it goes public
Everything we know about the Ensemble Health Partners IPO, plus information on how to buy in.
How to buy Fluence Energy (FLNC) stock in Canada when it goes public
Everything we know about the Fluence Energy IPO, plus information on how to buy in.
How to buy GlobalFoundries (GFS) stock in Canada when it goes public
Everything we know about the GlobalFoundries IPO, plus information on how to buy in.
How to buy LianBio (LIAN) stock in Canada when it goes public
Everything we know about the LianBio IPO, plus information on how to buy in.
How to buy Rent the Runway (RENT) stock in Canada when it goes public
Everything we know about the Rent the Runway IPO, plus information on how to buy in.
How to buy Solo Brands (DTC) stock in Canada when it goes public
Everything we know about the Solo Brands IPO, plus information on how to buy in.
How to buy Udemy (UDMY) stock in Canada when it goes public
Everything we know about the Udemy IPO, plus information on how to buy in.
How to buy Arteris (AIP) stock in Canada when it goes public
Everything we know about the Arteris IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.